Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Iran mass produces MS drug Ziferon
LKB1/STRAD promotes axon initiation during neuronal polarization.
Risks of immune system treatments.
Guillain-Barré Syndrome (42 Cases) Occurring During a Zika Virus Outbreak in French Polynesia.
Treatment satisfaction in multiple sclerosis.
Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Pages
« first
‹ previous
…
90
91
92
93
94
95
96
97
98
…
next ›
last »